← SynDRA

PURVALANOL B

SynDRA canonical compound SYN0001434 — structure-anchored drug synonym record

All known targets

• CDK2
• CDK4
• CDK5
• MAPK1
• MAPK3
• ADRB3
• CDK1
• SRPK2

Mechanisms of action (all sources)

• tyrosine kinase inhibitor
• CDK1 BINDER
• CDK5 INHIBITOR
• CDK2 INHIBITOR
• ADRB3 AGONIST

Cross-references

• PubChem CID: 448991
• ChEMBL: CHEMBL23254
• DrugBank: DB02733
• ChEBI: 49840
• PDB: PVB
• TTD: D0WS1V
• LINCS BRD: BRD-K41564320

Synonyms

• L-751250
• PURVALANOL
• Purvalanol B(NG-95)
• (R)-2-chloro-4-((2-((1-hydroxy-3-methylbutan-2-yl)amino)-9-isopropyl-9H-purin-6-yl)amino)benzoic acid
• (2R)-2-[[6-[(3-CHLORO-4-CARBOXYPHENYL)AMINO]-9-(1-METHYLETHYL)-9H-PURIN-2-YL]AMINO]-3-METHYL-1-BUTANOL
• CHEMBL23254
• CHEBI:49840
• NG-95
• C20H25ClN6O3
• 2-chloro-4-[[2-[[(2R)-1-hydroxy-3-methylbutan-2-yl]amino]-9-propan-2-ylpurin-6-yl]amino]benzoic acid
• J-502183
• PVB
• purvalanol-b
• RefChem:870378
• DTXCID801747716
• MFCD04118312
• PurvalanolB
• Tocris-1581
• 1v0p
• Purvalanol B(NG-95)?
• SCHEMBL27951
• BDBM7478
• GTPL7806
• NG95
• orb1300012
• SCHEMBL29546074
• EX-A354
• HMS3268E21
• HMS3412L09
• HMS3676L09
• MIA84454
• AKOS024456681
• CS-1714
• EBC-520453
• NCGC00025220-01
• NCGC00025220-02
• NCGC00025220-03
• NCGC00025220-04